Hautarztpraxis Dr. Kirschner
- Address
- Eppichmauergasse 1, 55116 Mainz, Germany
Hautarztpraxis Dr. Kirschner - Dermatological Research Center
Hautarztpraxis Dr. Kirschner is a specialized dermatological research center with expertise in investigating complex inflammatory skin conditions. The practice demonstrates particular proficiency in conducting clinical trials for challenging dermatologic disorders that significantly impact patients' quality of life.
- Hidradenitis Suppurativa treatment research in adult and adolescent populations
- Evaluation of novel biologic therapies for chronic inflammatory skin diseases
- Clinical investigation of moderate to severe dermatological conditions
The center specializes in Hidradenitis Suppurativa research, focusing on advanced therapeutic interventions including lutikizumab for patients aged 12 years and older. Their clinical trial portfolio emphasizes evaluating the efficacy of innovative treatments targeting the underlying inflammatory mechanisms of chronic skin diseases, with a commitment to addressing both signs and symptoms in moderate to severe cases.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hautarztpraxis Dr. Kirschner
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 3 Multicenter Randomized Double-Blind Placebo-Controlled Trial Evaluating Lutikizumab Efficacy and Safety in Moderate to Severe Hidradenitis Suppurativa | AbbVie Deutschland GmbH & Co. KG | Phase III | Not Recruiting | Dec 2024 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Lutikizumab | 1 | Unknown | 2024-12-12 | 2024-12-12 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.